Related Experiment Video
Updated: May 3, 2026
08:41
Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages
Published on: April 6, 2022
2.2K
Inflammasomes in cancer: a double-edged sword
Ryan Kolb1, Guang-Hui Liu, Ann M Janowski
1Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IA, 52242, USA.
Protein & Cell
|January 30, 2014
Summary
Inflammasomes, key inflammation drivers, have complex roles in cancer development and therapy. Understanding these roles is crucial for developing new cancer treatments targeting inflammasome pathways.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Chronic inflammation is linked to cancer development and progression.
- Inflammasomes are protein complexes that induce inflammatory cytokines like IL-1β and IL-18.
- Tumorigenesis and cancer therapy can activate inflammasomes via danger signals.
Purpose of the Study:
- To summarize the multifaceted roles of inflammasomes in cancer progression.
- To review the impact of inflammasomes on cancer therapy outcomes.
- To explore inflammasome components as potential therapeutic targets in oncology.
Main Methods:
- Literature review and synthesis of existing research on inflammasomes in cancer.
- Analysis of the specific functions of different inflammasome complexes in various cancer contexts.
- Evaluation of the dual roles of inflammasomes in promoting or inhibiting cancer.
Main Results:
- Inflammasome activation has context-dependent effects on cancer promotion and therapy.
- Specific inflammasome components and pathways are implicated in different stages of cancer.
- The pro-tumorigenic and anti-tumorigenic roles of inflammasomes are highlighted.
Conclusions:
- Inflammasome pathways offer potential novel therapeutic targets for cancer treatment.
- Caution is advised when targeting inflammasomes due to their complex immune functions.
- Further research is needed to precisely harness inflammasomes for effective cancer therapy.
Related Concept Videos
01:35Cancer Cell Migration through Invadopodia
2.5K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
01:24Caspases
8.7K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
8.7K
01:31The Intrinsic Apoptotic Pathway
6.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
01:17The Extrinsic Apoptotic Pathway
6.2K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
01:25Selectins
3.6K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.6K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K